Term Name: | erythromycin ethylsuccinate |
---|---|
Synonyms: | (2S,3R,4S,6R)-4-(dimethylamino)-2-{[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-2,10-dioxo-1-oxacyclotetradecan-6-yl]oxy}-6-methyl, E-Mycin, E-Mycin E, E.E.S, E.E.S 200, E.E.S 400, EES, EryPed, erythrocin ethyl succinate, erythromycin 2'-(ethyl butanedioate), erythromycin 2'-(ethyl succinate), erythromycin ethyl succinate, erythromycin ethylsuccinate, erythromycin mono(ethyl succinate), erythromycin, mono(ethyl succinate) (ester), Erythroped, Pediamycin, succinic acid, ethyl ester, monoester with erythromycin, Wyamycin E |
Definition: | A erythromycin derivative that is erythromycin A in which the hydroxy group at position 3R is substituted by a (4-ethoxy-4-oxobutanoyl)oxy group. It is used for the treatment of a wide variety of bacterial infections. |
Ontology: | ChEBI [CHEBI:31555] ( EBI ) |